159 related articles for article (PubMed ID: 27093735)
41. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
Jaskiw GE; Bongiovanni R
Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
[TBL] [Abstract][Full Text] [Related]
42. Dose-dependent response of central dopaminergic systems to metoclopramide in mice.
Bhosale KB; Balsara JJ; Gaonkar RK; Bhosale BB; Gupta SK
Indian J Exp Biol; 1997 Jun; 35(6):618-22. PubMed ID: 9357166
[TBL] [Abstract][Full Text] [Related]
43. Effects of baclofen on dopamine-dependent behaviors in mice.
Balsara JJ; Muley MP; Vaidya AS; Chandorkar AG
Psychopharmacology (Berl); 1981; 75(4):396-9. PubMed ID: 6803287
[TBL] [Abstract][Full Text] [Related]
44. Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized catalepsy response.
Oliveira LR; Dias FRC; Santos BG; Silva JLL; Carey RJ; Carrera MP
Behav Brain Res; 2016 Sep; 311():87-98. PubMed ID: 27173428
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
46. Early life stress causes refractoriness to haloperidol-induced catalepsy.
Marrocco J; Mairesse J; Bucci D; Lionetto L; Battaglia G; Consolazione M; Ravasi L; Simmaco M; Morley-Fletcher S; Maccari S; Nicoletti F
Mol Pharmacol; 2013 Aug; 84(2):244-51. PubMed ID: 23716620
[TBL] [Abstract][Full Text] [Related]
47. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
[TBL] [Abstract][Full Text] [Related]
48. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates.
Abrams DR; Bruno JP
Dev Psychobiol; 1992 Nov; 25(7):475-95. PubMed ID: 1459343
[TBL] [Abstract][Full Text] [Related]
49. Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.
Owolabi AR; Akanmu MA; Ukponmwan OE
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):117-24. PubMed ID: 18408917
[TBL] [Abstract][Full Text] [Related]
50. Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
Cohen SL; Knight M; Tamminga CA; Chase TN
Eur J Pharmacol; 1982 Sep; 83(3-4):213-22. PubMed ID: 6129145
[TBL] [Abstract][Full Text] [Related]
51. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
Hársing LG; Vizi ES
Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
[TBL] [Abstract][Full Text] [Related]
52. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
Lipska BK; Jaskiw GE; Braun AR; Weinberger DR
Biol Psychiatry; 1995 Aug; 38(4):255-62. PubMed ID: 8547448
[TBL] [Abstract][Full Text] [Related]
53. Significance of the cerebral dopaminergic neurotransmission for the individual differences in learning and memory (experiments on rats).
Kehayov R; Markovska V; Kamburova T
Acta Physiol Pharmacol Bulg; 1989; 15(1):76-82. PubMed ID: 2549763
[TBL] [Abstract][Full Text] [Related]
54. Dopamine is involved in the different patterns of copulatory behaviour of Roman high and low avoidance rats: studies with apomorphine and haloperidol.
Sanna F; Piludu MA; Corda MG; Argiolas A; Giorgi O; Melis MR
Pharmacol Biochem Behav; 2014 Sep; 124():211-9. PubMed ID: 24955864
[TBL] [Abstract][Full Text] [Related]
55. Dopaminergic mediation of beta-endorphin-induced catalepsy.
Van Loon GR; Kim C
Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
[TBL] [Abstract][Full Text] [Related]
56. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
57. On a prime role for newly synthesized dopamine in striatal function.
Shore PA; Dorris RL
Eur J Pharmacol; 1975 Feb; 30(2):315-8. PubMed ID: 1168577
[TBL] [Abstract][Full Text] [Related]
58. Distinct effects of haloperidol in the mediation of conditioned fear in the mesolimbic system and processing of unconditioned aversive information in the inferior colliculus.
Muthuraju S; Nobre MJ; Saito VM; Brandao ML
Neuroscience; 2014 Mar; 261():195-206. PubMed ID: 24384225
[TBL] [Abstract][Full Text] [Related]
59. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
60. Effect of supersensitivity of pre- and postsynaptic dopamine receptors on the activity of endogenous inhibitor of cAMP dependent protein kinase in rat striatum.
Szmigielski A; Szadowska A; Szmigielska H
Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):214-24. PubMed ID: 6098230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
